Charles Conover
2013
In 2013, Charles Conover earned a total compensation of $509.9K as Former Senior Vice President of Research & Development, Program Management at Enzon Pharmaceuticals, a 13% decrease compared to previous year.
Compensation breakdown
| Salary | $104,185 |
|---|---|
| Other | $405,680 |
| Total | $509,865 |
Conover received $405.7K in other compensation, accounting for 80% of the total pay in 2013.
Conover also received $104.2K in salary.
Rankings
In 2013, Charles Conover's compensation ranked 9,286th out of 12,286 executives tracked by ExecPay. In other words, Conover earned more than 24.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,286 out of 12,286 | 24th |
Division Manufacturing | 3,403 out of 4,612 | 26th |
Major group Chemicals And Allied Products | 1,077 out of 1,462 | 26th |
Industry group Drugs | 827 out of 1,156 | 29th |
Industry Biological Products, Except Diagnostic Substances | 137 out of 196 | 30th |
Source: SEC filing on April 16, 2014.
Conover's colleagues
We found five more compensation records of executives who worked with Charles Conover at Enzon Pharmaceuticals in 2013.
2013
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2013
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2013
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2013
Timothy Daly
Enzon Pharmaceuticals
Chief Accounting Officer
2013
Richard Feinstein
Enzon Pharmaceuticals